[Clinical trials with a new anti-myasthenic drug: N, N'-bis (2-diethylaminoethyl)-oxamide bis-2-chlorobenzyl chloride (Win 8077)].
D001593:Benzyl Compounds; D002712:Chlorides; D009157:Myasthenia Gravis / Q000628:therapy*; D010072:Oxamic Acid / Q000031:analogs & derivatives; D010277:Parasympathomimetics / Q000627:therapeutic use*
D001593:Benzyl Compounds; D002712:Chlorides; D010277:Parasympathomimetics; C026798:2-chlorobenzyl chloride; D010072:Oxamic Acid; C008728:oxamide
MYASTHENIA GRAVIS/therapy; PARASYMPATHOMIMETICS/therapeutic use
Essai clinique d'un nouvel antimyasthénique: le chlorure du N, N'-bis (2-diéthylaminoéthyl) oxamide bis-2-chlorobenzyl (Win 8077).